Spectrum Pharmaceuticals Highlights Six Abstracts of Clinical Data at the 2013 …DailyFinanceThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined …
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals Highlights … – 4-traders (press release)
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals Highlights …4-traders (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combin…
84-Year-Old Man Marks 100 Gallons Blood Donation – TopNews United States
TopNews United States |
84-Year-Old Man Marks 100 Gallons Blood Donation
TopNews United States Recently, it has been revealed that Mendenhall has made his 100 gallons blood donation and that too in last month. Asked from Mendenhall, he was of the view that donation of blood is a way to cope up from the grief of wife’s death as well as from death … Florida man reaches blood donation milestone: 100 gallonsMemphis Commercial Appeal 100 Gallons Blood Donated: Harold Mendenhall, 84, Donated Blood For 36 …iScienceTimes.com Florida Senior, 84, Donates His 100th Gallon of BloodWLTX.com Opposing Views –WCTV all 52 news articles » |
Planning ahead – Bend Bulletin
|
Planning ahead
Bend Bulletin June 7 — ORGAN CONCERT: Organist Mark Oglesby performs “Patriarchs, Prophets & Poetry: Old-Testament Organ Literature from Genesis to Jeremiah”; free, donations accepted; 7 p.m.; St. Francis of Assisi Catholic Church & School, 2450 N.E. 27th St., Bend … |
Exelixis (EXEL) Commences Phase 3 of Cabozantinib vs. Everolimus in MRCC … – StreetInsider.com (subscription)
Exelixis (EXEL) Commences Phase 3 of Cabozantinib vs. Everolimus in MRCC …StreetInsider.com (subscription)Exelixis, Inc. (Nasdaq: EXEL) has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic ren…
GSK eyes first-line use for leukaemia drug Arzerra – PMLiVE
|
GSK eyes first-line use for leukaemia drug Arzerra
PMLiVE However, the product has been slow to gain traction in the CLL market, mainly because it has been reserved for use as a second-line therapy and has found it hard to displace Roche’s Rituxan/MabThera (rituximab) as the dominant therapy in the anti-CD20 … |
Exelixis Begins Phase 3 Pivotal Trial Of Cabozantinib In Patients With MRCC – RTT News
Exelixis Begins Phase 3 Pivotal Trial Of Cabozantinib In Patients With MRCCRTT NewsExelixis Inc. (EXEL: Quote) announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal cell carcin…
Exelixis Begins Phase 3 Pivotal Trial Of Cabozantinib In Patients With MRCC – NASDAQ
Exelixis Begins Phase 3 Pivotal Trial Of Cabozantinib In Patients With MRCCNASDAQ(RTTNews.com) – Exelixis Inc. ( EXEL ) announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal ce…
Soccer improves heart health in diabetic men – Times of India
Times of India |
Soccer improves heart health in diabetic men
Times of India “We discovered that soccer training significantly improved the flexibility of the heart and furthermore, that the cardiac muscle tissue was able to work 29 per cent faster. This means that after three months of training, the heart had become 10 years … |
People on dialysis likelier to get heart attack – Times of India
Times of IndiaPeople on dialysis likelier to get heart attackTimes of IndiaScientists in Japan have discovered why patients, who are suffering from advanced kidney disease, and undergoing hemodialysis are at high risk to heart attacks and other cardiov…